End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 CAD | -6.07% |
|
+17.41% | +76.51% |
06-26 | Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
06-11 | Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CYBIN INC. | Bio Therapeutic Drugs | -6.07% | +17.41% | - | - | - | 206M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- CYBN Stock
- CLXP.F Stock
- Charts Cybin Inc.
- Comparison Chart